Author(s):
Chergizova B., Kharisova N., Mkhitaryan X., Ryspayeva G., Akhmetova M., Smirnova L., Ishigov I., Tatykayeva U., Tastanova G., Zhumabekova R.
Email(s):
harisova_nuriya@list.ru , harisovanuriya3@gmail.com , Mhitaryan@qmu.kz
DOI:
10.52711/0974-360X.2024.00681
Address:
Chergizova B.1, Kharisova N.1, Mkhitaryan X.1, Ryspayeva G.1, Akhmetova M.1, Smirnova L.2, Ishigov I.3, Tatykayeva U.3, Tastanova G.3, Zhumabekova R.3
1Karaganda Medical University” NCJSC, Karaganda, Kazakhstan.
2Kazan State Medical University, Kazan, Tatarstan, Russia.
3Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkistan, Kazakhstan.
*Corresponding Author
Published In:
Volume - 17,
Issue - 9,
Year - 2024
ABSTRACT:
In modern production conditions, industrial aerosols are still among the most common harmful occupational factors that determine the increased risk of developing occupational respiratory diseases among workers at industrial enterprises. The dust respiratory diseases are significantly common among workers in the mining and coal industries of Kazakhstan. In recent years, there has been a clear increase in the incidence of chronic dust bronchitis. The particular attention should be paid to such types of metal dust as dust of beryllium, vanadium, molybdenum, tungsten, cobalt and their compounds, under the influence of which not only peculiar damage to the lungs are observed, but also pronounced changes in other organs and systems. Dust of these metals, according to numerous authors, has a general toxic and toxic-allergic effect. An urgent problem of modern occupational medicine is the study of the role of exogenous and endogenous factors in the development of occupational pathology of the bronchopulmonary system. To identify groups at increased risk of developing dust pathology of the bronchopulmonary system, it is necessary to comprehensively study clinical and genetic factors, as well as determine the most significant diagnostic markers for the development of this pathology. An important advantage of inhaled anticholinergic drugs is the minimal frequency and severity of adverse events.The broncholytic effect is expressed in the form of inhibition of phosphodiesterase isoforms with a further increase in intracellular cAMP content and relaxation of smooth muscles of the respiratory tract. Immunomodulatory and anti-inflammatory effects of bronchodilators have also been established.
Cite this article:
Chergizova B., Kharisova N., Mkhitaryan X., Ryspayeva G., Akhmetova M., Smirnova L., Ishigov I., Tatykayeva U., Tastanova G., Zhumabekova R.. Pharmacological effect of Berotek and the leading mechanisms of Lung Pathology in miners Central Kazakhstan. Research Journal of Pharmacy and Technology. 2024; 17(9):4410-6. doi: 10.52711/0974-360X.2024.00681
Cite(Electronic):
Chergizova B., Kharisova N., Mkhitaryan X., Ryspayeva G., Akhmetova M., Smirnova L., Ishigov I., Tatykayeva U., Tastanova G., Zhumabekova R.. Pharmacological effect of Berotek and the leading mechanisms of Lung Pathology in miners Central Kazakhstan. Research Journal of Pharmacy and Technology. 2024; 17(9):4410-6. doi: 10.52711/0974-360X.2024.00681 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-9-42
REFERENCES:
1. Shaykhlislamova E.R., Karimova L.K., Volgareva A.D., Muldasheva N.A., Kondrova N.S. Hygienic assessment of working conditions and characteristics of the health of workers engaged in underground mining of copper ores. Materials of the X All-Russian Scientific and Practical Conference with International Participation. – PERM. 2020; 2: 11-16.
2. Borisova A.V., Finochenko V.A., Finochenko T.A. The Use of the Expert Method in Solving the Issues of Choosing the Instrumentation of the Procedure for Controlling Production Factors. Procced. IOP Conference Series: Earth and Environmental Science. – R-on-D. 2021: R. 022022.
3. Bukhtiyarov I.V., Chebotarev A.G., Kuryerov N.N. Current issues of improving working conditions and preserving the health of workers at mining enterprises. Occupational Medicine and Industrial Ecology. 2019; 7 (59): 424–429.
4. Qi X.M., Luo Y., Song M.Y. et al. Pneumoconiosis: Current Status and Future Prospects. Chinese Medical Journal. 2021; 134: 898-907.
5. Preobrazhenskaya E.A., Sukhova A.V., Zorkina L.A. and others. Hygienic assessment of working conditions and health status of workers at mining and processing plants. Hygiene and Sanitation. 2016; 95(11): 1065–1070.
6. Kazitskaya A.S., Panev N.I., Dykina T.K., Gulyaeva O.N. Genetic and biochemical aspects of the formation of occupational chronic dust bronchitis. Occupational Medicine and Industrial Ecology. 2019; 6.
7. Zaitseva N.V., Ustinova O.Yu., Alekseev V.B. and others. Features of production-related diseases among miners engaged in underground mining of chrome ores. Occupational Medicine and Industrial Ecology. 2018; 10: 6–12.
8. Chebotarev A.G. Risks of developing occupational diseases of dust etiology among workers of mining enterprises//Mining Industry. 2018; 3 (139): 66.
9. Shlyapnikov D.M., Kostarev V.G. Assessment and forecast of occupational risk among workers of non-ferrous metallurgy enterprises. Occupational Medicine and Industrial Ecology. 2014; 12: 16-18.
10. Sukhova A.V., Kryuchkova E.N. Occupational risk to the health of workers in processing plants. Materials of the X All-Russian Scientific and Practical Conference with International Participation. PERM. 2020; 2: 28-32.
11. Syurin S.A., Kovshov A.A. Working conditions and work-related pathologies at enterprises located in Chukotka autonomous area. Health Risk Analysis. 2020. 4: 99-106.
12. Chergizova V. Changes in the respiratory system indicators and the leading mechanisms of pathological disorders of the airway patency by workers of the tungsten-molybdenum mine. Official Journal of the European Society of Pathology/Committees and Organizers 33rd European Congress of Pathology. PS-22 Pulmonary Pathology. P.171.
13. Coca G., Castrillon O.D., Ruiz S. et al. Sustainable evaluation of environmental and occupational risks scheduling flexible job shop manufacturing systems. Journal of Cleaner Production. 2019; 209: 146-168.
14. Wilk A., Garland S., Falk N. Less Common Respiratory Conditions: Occupational Lung Diseases. FP Essent. 2021; 502: 11-17.
15. Austin E.K., James C., Tessier J. Early Detection Methods for Silicosis in Australia and Internationally: A Review of the Literature. International Journal of Environmental Research and Public Health. 2021; 18: 8123-1-8123-24.
16. Mazhaeva T.V., Dubenko S.E. Commitment to a healthy lifestyle and the performance index of industrial workers in the Sverdlovsk region. Hygiene and Sanitation. 2021; 100(12): 1449-1454.
17. Khamida R. Abdikadirova, Kymbat Ye. Amreyeva, Saule B. Zhautikova, Bibigul T. Chergizova, Yulia P. Talaspekova, Saule Sh. Atshabarova. Morphological changes in the hepatic tissue at the impact of industrial copper-bearing dust in the experiment // Scientific Foundation SPIROSKI, Skopje, Republic of Macedonia Open Access Macedonian Journal of Medical Sciences. 2020; 8(E): S. 653-656.
18. Bezrukova G.A., Pozdnyakov M.V., Novikova T.A. The use of digital technologies in social and hygienic monitoring of the health status of workers in hazardous working conditions. Hygiene and Sanitation. 2021; 100(10): 1157-1162.
19. Galikeeva A. Sh., Idrisova G.B., Stepanov E.G. and others. Factors in the formation of the health of the working population. Social Aspects of Population Health. 2022; 2: 1-18.
20. Petrov A.G. etc. Modern problems of medical and pharmaceutical care for occupational diseases. Medicine in Kuzbass. 2022; 21(3): 126-129.
21. Bukhtiyarov I.V., Kuzmina L.P., Izmerova N.I. and others. Improving the mechanisms for identifying early signs of health disorders to preserve working longevity.Occupational Medicine and Industrial Ecology. 2022; 62(6): 377-387.
22. Chebotarev A.G. Risks of development of occupational diseases of dust etiology in workers of mining enterprises. Mining Industry. 2018; 3(139):66.
23. Kazitskaya A.S., Panev N.I., Dykina T.K., Gulyaeva O.N. Genetic and biochemical aspects of the formation of occupational chronic dust bronchitis. Occupational Medicine and Industrial Ecology. 2019; 6: 342-347. https://doi.org/10.31089/1026-9428-2019-6-342-347.
24. Chebotarev A.G. The state of working conditions and occupational morbidity of workers of mining enterprises. Mining Industry. 2018; 1(137): 92-95.
25. Bioradar S.M., Vinit Kumar K., Sanad K., Vinay Kumar N.S., P. Avinash, Ambaly A.P., Shashidhar Devaramani, Akram Naikwadi, Abhishek B, S.R. Avasti, Prashant Jorapur. The effect of breathing exercises and inhalation techniques on the quality of life of patients with asthma and COPD. Research Journal of Pharmacy and Technology. 2024; 17(1): 368-369. doi: 10.52711/0974-360X.2024.00057.
26. Sanal Nalkar, Shubhangi Star, Mareesh Redkar, Priyanka Mohr, Pooja With you. Development of a user-friendly analytical method and validation of salmeterol xynafoate, an anti-asthma drug, both in bulk and ready-made form. Research Journal of Pharmacy and Technology. 2024; 17(1): 358-2. doi: 10.52711/0974-360X.2024.00055.
27. Dharini Bupati, Akshata J.S., Uma Boogie, Hema Shiva, Arun K.P., Deepalakshmi Mani. The analysis of adverse drug reactions associated with anti–tuberculosis drugs is a retrospective study. Research Journal of Pharmacy and Technology. 2022; 15(4): 1483-6. 10.52711/0974-360X.2022.00246
28. Ramana Want, Rangapuram Vasanti, Tamrat Bala Bala, Kaliperumal J. Current clinical expectations for the use of arbidol against COVID-19: possibilities. Research Journal of Pharmacy and Technology. 2022; 15(4): 1653-8. 10.52711/0974-360 X.2022.00276.
29. Israa Hussein Hamza, Nur Al-Huda Ali A.H. Said, Ala N. Mohammed Ali. The risk of genetic polymorphism of immune genes in the development of respiratory allergic diseases. Research Journal of Pharmacy and Technology. 2022; 15(4): 1768-4. doi: 10.52711/0974-360X.2022.00296.
30. Sonal Nalkar, Shubhangi Star, Mareesh Redkar, Priyanka Mohr, Pooja with you. Development of a user-friendly analytical method and validation of salmeterol xynafoate, an anti-asthma drug, both in bulk and ready-made form. Research Journal of Pharmacy and Technology. 2024; 17(1): 358-2. doi: 10.52711/0974-360X.2024.00055.
31. Suman Sharma, Devinder Singh, Ashima Katyal, Paramjit S. Gil, Surender Jangra, Bhupender Bhardwaj, Soul Glass. Assessment of the outcome of the disease in patients with COVID-19 with concomitant diseases: the experience of the Tertiary Care Center in Northern India. Research Journal of Pharmacy and Technology. 2024; 17(1): 31-6. doi: 10.52711/0974-360X.2024.00006.
32. Sandhoshini Meena, Somasundaram I. The effect of salbutamol on patients with chronic obstructive pulmonary disease: a prospective observational study of clinical interventions. Research Journal of Pharmacy and Technology. 2020; 13(10): 4621-4624. doi: 10.5958/0974-360X.2020.00813.6.
33. Shikhas Aziz, Sarina Kalatoduvil, Shaguf Bashir, Shafana Parvin Kankadil, Dilip Chandrashekar. Inhaler use in patients with asthma or chronicobstructive pulmonary disease: errors and problems with adherence. Research Journal of Pharmacy and Technology. 2020; 13(9): 4130-4134. doi: 10.5958/0974-360X.2020.00729.5.
34. Cavita. R, Deepti. VD, Sangita. S. Evaluation of the correct technique of using inhalationdevices in patients with obstructive respiratory tract diseases in a tertiary hospital. Research Journal of Pharmacy and Technology. 2020; 13(6): 2873-2876. doi: 10.5958/0974-360X.2020.00512.0.
35. Rasha Saadi Abbas, Manal Khalid Abdulridha, Mostafa Abdalfatah Shafek. Study the relationship between asthma severity and the AVO blood type phenotype ina sample of Iraqi patients with chronic bronchial asthma.Research Journal of Pharmacy and Technology. 2020; 13(1): 47-54. doi: 10.5958/0974-360X.2020.00008.6.
36. Shikhas Aziz, Sarina Kalatoduvil, Shaguf Bashir, Shafana Parvin Kankadil, Dilip Chandrashekar. Inhaler use in patients with asthma or chronic obstructive pulmonary disease:errors and problems with adherence. Research Journal of Pharmacy and Technology. 2020; 13(9): 4130-4134. doi: 10.5958/0974-360X.2020.00729.5.